English
Home > Products > CAS NO 122-51-0

China CAS NO 122-51-0 Factory

Our advancement depends over the superior machines, exceptional talents and continually strengthened technology forces for CAS NO 122-51-0,122-51-0,Triethyl orthoformate, We welcome new and aged shoppers from all walks of daily life to call us for long term business associations and mutual accomplishment!
CAS NO 122-51-0, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Related Products

Hot Products

  • 1-Boc-3-(cyanomethylene)azetidine

    1-Boc-3-(cyanomethylene)azetidine

    Product Name:1-Boc-3-(cyanomethylene)azetidine
    Molecular Formula:C10H14N2O2
    Molecular Weight:194.23
    CAS Registry Number:1153949-11-1
  • Ceftaroline fosamil

    Ceftaroline fosamil

    Product Name:Ceftaroline fosamil
    Molecular Formula:C24H27N8O11PS4
    Molecular Weight;762.7519
    CAS Registry Number;866021-48-9
  • CERIUM

    CERIUM

    Product Name:CERIUM
    Molecular Formula:Ce
    Molecular Weight:140.116
    CAS Registry Number:7440-45-1
  • Vancomycin Hydrochloride

    Vancomycin Hydrochloride

    Product Name:Vancomycin Hydrochloride
    Molecular Formula:C66H75Cl2N9O24.HCl
    Molecular Weight:1485.72
    CAS Registry Number;1404-93-9
  • tert-Butylchlorodiphenylsilane

    tert-Butylchlorodiphenylsilane

    Product Name:tert-Butylchlorodiphenylsilane
    Molecular Formula:C16H19ClSi
    Molecular Weight:274.86
    CAS Registry Number:58479-61-1
  • Podophyllotoxin

    Podophyllotoxin

    Product Name:Podophyllotoxin
    Molecular Formula:C22H22O8
    Molecular Weight:414.41
    CAS Registry Number;518-28-5
  • Related Blog
  • Reviews

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept